{
  "trial_id": "NCT03099564",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "study",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Written informed consent and HIPAA authorization for release of personal health information prior to registration.",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "ECOG Performance Status of 0-1",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Is currently participating and receiving study therapy or has participated in a study of an investigational agent and received study therapy or used an investigational device within 4 weeks of study registration.",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Active autoimmune disease that has required systemic treatment in the past 2 years (i.e. with use of disease modifying agents, corticosteroids or immunosuppressive drugs).",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "The patient is a 3-day-old Asian female infant presenting with jaundice that started a day ago. She was born at 38w3d of gestation, after an uncomplicated pregnancy.",
  "_meta": {
    "topic_id": "39",
    "trial_id": "NCT03099564",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}